Magellan Health, Inc. (NASDAQ:MGLN) recent gain occurred on low volume with 0.86 million contracts changing hands on 06-Dec-18. That’s down from its daily average of 307.56 million contracts. The first sale was made at $54.44 but later the stock became weaker, and closed with a gain of 0.62%. It was last traded at $55.49 apiece.Magellan Health, Inc. (MGLN): Outperform Candidate With 32.76% Upside Potential
Magellan Health, Inc. is maintained at an average outperform rating by 3 stock analysts, and there are at least 4.16% of shares outstanding that are currently legally short sold. The shares went down by -20.27% in value last month. Year-to-date it plunged -42.53%. Analysts are turning out to be more optimistic than before, with 2 of analysts who cover Magellan Health, Inc. (NASDAQ:MGLN) advice adding it to buy candidate list. Wall Street experts also assign a $73.67 price target on Magellan Health, Inc., pointing towards a 32.76% rally from current levels. The stock is trading for about -50.57% less than its 52-week high.
Revenue scored 1.97% growth from the previous quarter, coming up with $1.85 billion.MGLN Retreats -0.91% In A Week
This company shares (MGLN) so far managed to recover 6.06% since collapsing to its 52-week low. Over a week, it has seen its stock price volatility to stay at 4.36% while shortening the period to a week, volatility was 4.19%. The share price has yet to cross its 20 days moving average, floating at a distance of -3.7% and sits -13.25% lower versus its 50 days moving average. When looking at the past five sessions, the stock returned -0.91% losses and is down by -34.38% compared with its 200-day moving average of $85.21. Also, Magellan Health, Inc. (MGLN) needs to overturn a -42.02% decrease it experienced over the past twelve months.
As regular trading ended, Ultrapar Participacoes S.A. (UGP) stock brought in a $0.41 rise to $12.51. The day started at a price of $11.91 but then traded as high as $12.54 before giving part of the gains back. As for this week, analysts appear content to stick with their neutral outlook with the consensus call at 2.8. Ultrapar Participacoes S.A. is given 1 buy-equivalent recommendations, 0 sells and 1 holds. The company shares sank -52.75% from their peak of $26.48 and now has a $7.13 billion market value of equity.
UGP’s mean recommendation on Reuter’s scale presents no change from 2.5 thirty days ago to 2.5 now, which indicates a hold consensus from the analyst community. They see Ultrapar Participacoes S.A. (UGP) price hitting a mean target of $17.2 a share, meaning the stock still has potential that could lift the price another 37.49% . Also, the recent close suggests the stock is underpriced by 36.45% compared to the most bullish target.
The company had seen its current volume reaching at 1.16 million shares in the last trade. That compares with the recent volume average of 991.86 million. At the close of regular trading, its last week’s stock price volatility was 3.78% which for the month reaches 3.67%. Ultrapar Participacoes S.A. dipped to as low as $11.81 throughout the day and has returned -44.96% in this year. At one point in the past year, the shares traded as low as $8.86 but has recovered 41.2% since then.